Prostate International

Papers
(The TQCC of Prostate International is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Up- and downgrading in single intermediate-risk positive biopsy core prostate cancer43
Topical antiseptic at time of transrectal ultrasound prostate biopsy is associated with fewer severe clinical infections and improves antibiotic stewardship31
Oncological outcomes after radical prostatectomy of localized prostate cancer: stratified by magnetic resonance imaging and risk classification23
Does androgenic alopecia aggravate the risk of prostate cancer? Evidence from Mendelian randomization23
Is antibiotic prophylaxis still mandatory for transperineal prostate biopsy? Results of a comparative study17
Association between pelvic lymph node dissection and survival among patients with prostate cancer treated with radical prostatectomy16
Prostate-specific antigen kinetics in hypofractionated radiation therapy alone for intermediate- and high-risk localized prostate cancer16
Treatment outcomes with radium-223 in patients with metastatic castration-resistant prostate cancer with bone metastasis in real-world practice: a multiinstitutional study15
The association between behavioral habits and physical health status in prostate cancer patients: a large US national health-related survey15
Performance of Ga-68 PSMA PET/CT for diagnosis and grading of local prostate cancer14
Association between preradiation therapy prostate-specific antigen levels and radiation therapy failure after prostatectomy: a propensity score matched analysis13
Safety and efficacy of extracorporeal shockwave therapy on chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled study13
Rebiopsy rate after transperineal or transrectal prostate biopsy12
Changing trends in robot-assisted radical prostatectomy: Inverse stage migration—A retrospective analysis12
Simplified Chinese version of the international prostate symptom score and the benign prostatic hyperplasia impact index: cross-cultural adaptation, reliability, and validity for patients with benign 12
Association between preoperative prostate-specific antigen levels and mortality in high- and intermediate-grade prostate cancer patients who received radical prostatectomy: Findings from the SEER data12
The impact of obesity and sexual behavior on prostate cancer risk is mediated by testosterone levels: a mendelian randomization study and mediation analysis11
Real-world prostate-specific antigen reduction and survival outcomes of metastatic hormone-sensitive prostate cancer patients treated with apalutamide: An observational, retrospective, and multicentre11
Biopsy-free radical prostatectomy: a narrative review considering rationale, limitations, and current data10
Revision of CHAARTED and LATITUDE criteria among Japanese de novo metastatic prostate cancer patients10
Impact of inflammatory bowel disease on radical prostatectomy outcomes and costs of care9
The prevalence of dyslipidemia in patients with prostate cancer9
Update on the management of benign prostatic hyperplasia and the role of minimally invasive procedures9
Assessing the influence of prostate tissue traits on Gallium-68 prostate-specific membrane-antigen positron-emission tomography/computed tomography: predictive factors for image positivity and locoreg8
The feasibility of distance to the tumor of biopsy cores to estimate the extracapsular extension8
High-power holmium laser versus thulium fiber laser for endoscopic enucleation of the prostate in patients with glands larger than 80 ml: Results from the Prostate Endoscopic EnucLeation study group8
Efficacy of tamsulosin 0.4 mg for the treatment in male with the international Prostate Symptom Score ≥ 20 compared with tamsulosin 0.2 mg8
Evaluation of the efficiency of transurethral enucleation with bipolar energy according to prostate volume for patients with benign prostate hyperplasia8
Observation with or without late radiotherapy is equivalent to early radiotherapy in high-risk prostate cancer after radical prostatectomy: A SEER-Medicare analysis on trends, survival outcomes, and c8
Diagnostic performance of MRI for prediction of recurrent prostate cancer after high-intensity focused ultrasound: a systematic review and meta-analysis8
Comparing the efficacy of tadalafil and tamsulosin for managing erectile dysfunction and lower urinary tract symptoms in prostate brachytherapy patients: a prospective study8
Time to castrate the cost? the rising expense of chemical castration for the management of prostate cancer8
The oncologic and safety outcomes of low-dose-rate brachytherapy for the treatment of prostate cancer8
A randomized, active-controlled, multicenter, phase 3 clinical trial to evaluate the efficacy and safety of GV1001 in patients with benign prostatic hyperplasia8
Clinical significance of primary tumor progression in metastatic hormone-sensitive prostate cancer8
A meta-analysis on the use of radiotherapy after prostatectomy: adjuvant versus early salvage radiation7
Irreversible electroporation for prostate cancer using PSMA PET-CT7
Comparison of the efficacy and safety of holmium laser enucleation of the prostate and prostate artery embolization: Short-term follow-up results7
Short course of dutasteride in treatment of a refractory category IIIB chronic prostatitis (A placebo-controlled study)7
Negative magnetic resonance imaging cannot be used to omit an initial prostate biopsy - An ambispective study7
Comparative adverse event profiles of triplet therapy versus docetaxel-based therapy in patients with metastatic prostate cancer: a multicenter retrospective study6
Utility of transperineal template-guided mapping prostate biopsy in biopsy-naïve men with PI-RADS 1-2 on multiparametric magnetic resonance imaging6
Single-port and multiport robot-assisted radical prostatectomy: A meta-analysis6
Chronological changes of lower urinary tract symptoms after low-dose-rate brachytherapy for prostate cancer using SpaceOAR® system6
Preoperative prostatic artery embolization before transurethral resection of the prostate for prostate glands larger than 80 mL: the first randomized controlled trial6
Prostate diseases and microbiome in the prostate, gut, and urine6
Application of robotics in the treatment of benign prostatic hyperplasia: a narrative review6
Does music from noise-canceling headphones have a beneficial effect on men undergoing transrectal ultrasound-guided prostate biopsy?6
Open simple prostatectomy and robotic simple prostatectomy for large benign prostatic hyperplasia: Comparison of safety and efficacy6
RNA-seq profile of African American men with a clinically localized prostate cancer6
A new parameter to increase the predictive value of multiparametric prostate magnetic resonance imaging for clinically significant prostate cancer in targeted biopsies: lesion density6
0.032833814620972